These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16575360)

  • 1. [Obstetrical management of patients at risk of neonatal lupus syndrome: review of the literature].
    Costedoat-Chalumeau N; Amoura Z; Villain E; Cohen L; Fermont L; Le Thi Huong D; Vauthier D; Georgin-Lavialle S; Wechsler B; Dommergues M; Piette JC
    J Gynecol Obstet Biol Reprod (Paris); 2006 Apr; 35(2):146-56. PubMed ID: 16575360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neonatal lupus syndrome: Literature review].
    Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N
    Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neonatal lupus syndrome: review of the literature].
    Costedoat-Chalumeau N; Amoura Z; Le Thi Hong D; Georgin S; Vauthier D; Sebbouh D; Francès C; Villain E; Wechsler B; Piette JC
    Rev Med Interne; 2003 Oct; 24(10):659-71. PubMed ID: 14550519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
    Ayed K; Gorgi Y; Sfar I; Khrouf M
    Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases.
    Fredi M; Argolini LM; Angeli F; Trespidi L; Ramoni V; Zatti S; Vojinovic T; Donzelli D; Gazzola FG; Xoxi B; Andreoli L; Lojacono A; Ferrazzi E; Montecucco C; Chighizola CB; Meroni PL; Franceschini F; Cimaz R; Caporali R; Tincani A; Gerosa M
    Clin Exp Rheumatol; 2023 Mar; 41(3):685-693. PubMed ID: 36377571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neonatal lupus: a fetal-maternal immunisation model?].
    Amoura Z; Arnaud L; Mathian A
    Bull Acad Natl Med; 2012 Nov; 196(8):1625-37. PubMed ID: 24313017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of congenital heart block in children of SSA-positive mothers.
    Brucato A
    Rheumatology (Oxford); 2008 Jun; 47 Suppl 3():iii35-7. PubMed ID: 18504284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options.
    Costedoat-Chalumeau N; Amoura Z; Villain E; Cohen L; Piette JC
    Arthritis Res Ther; 2005; 7(2):69-73. PubMed ID: 15743492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.
    Brucato A; Cimaz R; Caporali R; Ramoni V; Buyon J
    Clin Rev Allergy Immunol; 2011 Feb; 40(1):27-41. PubMed ID: 20012231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal lupus erythematosus in Japan: a review of the literature.
    Kobayashi R; Mii S; Nakano T; Harada H; Eto H
    Autoimmun Rev; 2009 May; 8(6):462-6. PubMed ID: 19162245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block.
    Costedoat-Chalumeau N; Georgin-Lavialle S; Amoura Z; Piette JC
    Lupus; 2005; 14(9):660-4. PubMed ID: 16218462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial.
    Friedman DM; Llanos C; Izmirly PM; Brock B; Byron J; Copel J; Cummiskey K; Dooley MA; Foley J; Graves C; Hendershott C; Kates R; Komissarova EV; Miller M; Paré E; Phoon CK; Prosen T; Reisner D; Ruderman E; Samuels P; Yu JK; Kim MY; Buyon JP
    Arthritis Rheum; 2010 Apr; 62(4):1138-46. PubMed ID: 20391423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of neuro-psychiatric dysfunction in anti-SSA/SSB exposed children with and without neonatal lupus.
    Askanase AD; Izmirly PM; Katholi M; Mumtaz J; Buyon JP
    Lupus; 2010 Mar; 19(3):300-6. PubMed ID: 20008445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
    Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
    Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry.
    Buyon JP; Hiebert R; Copel J; Craft J; Friedman D; Katholi M; Lee LA; Provost TT; Reichlin M; Rider L; Rupel A; Saleeb S; Weston WL; Skovron ML
    J Am Coll Cardiol; 1998 Jun; 31(7):1658-66. PubMed ID: 9626848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal lupus: Follow-up in infants with anti-SSA/Ro antibodies and review of the literature.
    Zuppa AA; Riccardi R; Frezza S; Gallini F; Luciano RM; Alighieri G; Romagnoli C; De Carolis S
    Autoimmun Rev; 2017 Apr; 16(4):427-432. PubMed ID: 28212920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
    Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
    J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.